av/sunshine-biopharma--big.svg

NASDAQ:SBFM

Sunshine Biopharma, Inc.

  • Stock

1.41

+4.44%

−0.16

USD last updated 27/07 01:51:33

Last Close

1.57

25/07 20:25

Market Cap

8.06M

Beta: −1.00

Volume Today

73.81K

Avg: 127.64K

PE Ratio

−0.22

PFCF: −0.67

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills m...Show More

    Earnings

    Earnings per Share (Estimate*)

    -150-100-502020-09-292021-08-092022-08-032024-03-282024-12-06

    Revenue (Estimate*)

    5M10M15M2020-09-292021-08-092022-08-032024-03-282024-12-06

    *Estimate based on analyst consensus